RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds released “The RiverPark/Next Century Growth Fund” Q4 2023 investor letter in partnership with Next Century Growth Investors, LLC. A copy of the same can be downloaded here. The fund returned 4.75% in the fourth quarter compared to a 12.75% return […]
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) had its price objective lifted by Citigroup from $31.00 to $38.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a “neutral” rating on the medical device company’s stock. Citigroup’s price target indicates a potential upside of 9.86% from the stock’s previous close. Several […]
MINNEAPOLIS (Legal Newsline) - Medtronic has defeated a shareholder class action lawsuit that alleged the company hid problems with an insulin pump's FDA approval.